Discovery of a novel vulnerability in aggressive lymphoma could change future therapy

Researchers at the University of Cologne discovered that the protein cFLIP can override aggressive lymphoma's cell death defenses, potentially improving treatment effectiveness for DLBCL and ABC-DLBCL subtypes.